Affiliation:
1. From the University of California, San Francisco, Department of Surgery, Endocrine Surgery and Oncology Program, San Francisco, California.
Abstract
Hereditary medullary thyroid cancer syndromes comprise familial medullary thyroid cancer (FMTC) and multiple endocrine neoplasia types 2A and 2B. Hereditary medullary thyroid cancers have an autosomal dominant pattern of inheritance and are caused by activating germline point mutations in the RET proto-oncogene. Evaluation of the onset, extent, and progression of hereditary medullary thyroid cancer associated with specific RET mutations has enabled clinicians to treat patients based on the level of risk associated with their specific mutation. Children identified by RET screening to be at risk for the development of medullary thyroid cancer can be treated with prophylactic thyroidectomy before developing the disease. This review covers the diagnosis, evaluation, timing of surgical management, and optimal follow-up of patients with hereditary medullary thyroid cancer syndromes.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Peptide Receptor Radionuclide Therapy in Patients With Advanced Progressive Medullary Thyroid Cancer;Clinical Nuclear Medicine;2023-01-12
2. Cancer of the Endocrine System;Abeloff's Clinical Oncology;2020
3. Thyroid Cancer;Thyroid Disease;2020
4. Role of Surgery in Cancer Management;Basics of Planning and Management of Patients during Radiation Therapy;2018
5. Endocrine Pathology;Essentials of Anatomic Pathology;2016